The pathogenic haploinsufficiency of the HHT gene products yields a deregulated genetic expression pattern in the cells most targeted in HHT, the endothelial cells (Fernandez-L et al., 2007a). This evidence concerns the gene ACVRL1 and hereditary hemorrhagic telangiectasia.